Cargando…
Orbital Exenteration in Recurrence Cancer: 5 Years Experience
Introduction: The purpose of this study was to assess the overall survival (OS) and disease-free survival (DFS) of patients who underwent orbital exenteration for periorbital, conjunctival, and primary intraorbital carcinomas. Additionally, we assessed the outcomes of anterior retrograde temporalis...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573591/ https://www.ncbi.nlm.nih.gov/pubmed/37834824 http://dx.doi.org/10.3390/jcm12196180 |
_version_ | 1785120499912671232 |
---|---|
author | Barbera, Giorgio Todaro, Mattia Saponaro, Gianmarco Gasparini, Giulio Moro, Alessandro |
author_facet | Barbera, Giorgio Todaro, Mattia Saponaro, Gianmarco Gasparini, Giulio Moro, Alessandro |
author_sort | Barbera, Giorgio |
collection | PubMed |
description | Introduction: The purpose of this study was to assess the overall survival (OS) and disease-free survival (DFS) of patients who underwent orbital exenteration for periorbital, conjunctival, and primary intraorbital carcinomas. Additionally, we assessed the outcomes of anterior retrograde temporalis muscle flap restoration. Methods: For all patients who had orbital exenteration in the previous five years, a non-comparative retrospective assessment of their medical records, histology, and radiographic imaging was carried out. We investigated the relationships between the various qualitative factors using Cramer’s V Kaplan–Meier (KM) analysis. For each of the patient’s categorical factors that were of relevance, estimates of the survival distribution were displayed, and log-rank tests were used to determine whether the survival distributions were equal. Results: This study looks at 19 participants. The sample is made up of 13 men (68%) and 6 women (32%). The degree of relationship (Cramer’s V index) between lymph node metastases (N) and the existence of distant metastases (M) is high, at 64%, and is statistically significant because the p-value is 0.0034 < 0.005. Lymph node metastases had a statistically significant impact on overall survival (p = 0.04 < 0.05). Thirteen of the nineteen patients tested had no palsy (68%). There was no one presenting a CSF leak. Conclusion: Our findings show how crucial it is to identify any lymph node involvement that orbital neoplasms may have. In patients who have received many treatments, sentinel lymph node biopsy (SLNB) may be used to determine the stage and spread of the cancer. To determine whether additional tumor characteristics may be explored, more expertise in the SLNB field for patients with orbital cancer who have received many treatments may be helpful. To prevent additional scarring and to be comparable to previous techniques for facial nerve lesions, the anterior retrograde approach and the transorbital procedure for temporal muscle flap in-setting are both effective methods. |
format | Online Article Text |
id | pubmed-10573591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105735912023-10-14 Orbital Exenteration in Recurrence Cancer: 5 Years Experience Barbera, Giorgio Todaro, Mattia Saponaro, Gianmarco Gasparini, Giulio Moro, Alessandro J Clin Med Article Introduction: The purpose of this study was to assess the overall survival (OS) and disease-free survival (DFS) of patients who underwent orbital exenteration for periorbital, conjunctival, and primary intraorbital carcinomas. Additionally, we assessed the outcomes of anterior retrograde temporalis muscle flap restoration. Methods: For all patients who had orbital exenteration in the previous five years, a non-comparative retrospective assessment of their medical records, histology, and radiographic imaging was carried out. We investigated the relationships between the various qualitative factors using Cramer’s V Kaplan–Meier (KM) analysis. For each of the patient’s categorical factors that were of relevance, estimates of the survival distribution were displayed, and log-rank tests were used to determine whether the survival distributions were equal. Results: This study looks at 19 participants. The sample is made up of 13 men (68%) and 6 women (32%). The degree of relationship (Cramer’s V index) between lymph node metastases (N) and the existence of distant metastases (M) is high, at 64%, and is statistically significant because the p-value is 0.0034 < 0.005. Lymph node metastases had a statistically significant impact on overall survival (p = 0.04 < 0.05). Thirteen of the nineteen patients tested had no palsy (68%). There was no one presenting a CSF leak. Conclusion: Our findings show how crucial it is to identify any lymph node involvement that orbital neoplasms may have. In patients who have received many treatments, sentinel lymph node biopsy (SLNB) may be used to determine the stage and spread of the cancer. To determine whether additional tumor characteristics may be explored, more expertise in the SLNB field for patients with orbital cancer who have received many treatments may be helpful. To prevent additional scarring and to be comparable to previous techniques for facial nerve lesions, the anterior retrograde approach and the transorbital procedure for temporal muscle flap in-setting are both effective methods. MDPI 2023-09-25 /pmc/articles/PMC10573591/ /pubmed/37834824 http://dx.doi.org/10.3390/jcm12196180 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Barbera, Giorgio Todaro, Mattia Saponaro, Gianmarco Gasparini, Giulio Moro, Alessandro Orbital Exenteration in Recurrence Cancer: 5 Years Experience |
title | Orbital Exenteration in Recurrence Cancer: 5 Years Experience |
title_full | Orbital Exenteration in Recurrence Cancer: 5 Years Experience |
title_fullStr | Orbital Exenteration in Recurrence Cancer: 5 Years Experience |
title_full_unstemmed | Orbital Exenteration in Recurrence Cancer: 5 Years Experience |
title_short | Orbital Exenteration in Recurrence Cancer: 5 Years Experience |
title_sort | orbital exenteration in recurrence cancer: 5 years experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573591/ https://www.ncbi.nlm.nih.gov/pubmed/37834824 http://dx.doi.org/10.3390/jcm12196180 |
work_keys_str_mv | AT barberagiorgio orbitalexenterationinrecurrencecancer5yearsexperience AT todaromattia orbitalexenterationinrecurrencecancer5yearsexperience AT saponarogianmarco orbitalexenterationinrecurrencecancer5yearsexperience AT gasparinigiulio orbitalexenterationinrecurrencecancer5yearsexperience AT moroalessandro orbitalexenterationinrecurrencecancer5yearsexperience |